# Efficacy and Safety Study of PG201 Tablet in Patients With Osteoarthritis

> **NCT01122485** · PHASE2 · WITHDRAWN · sponsor: **Helixmith Co., Ltd.**

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **OTHER:** PG201
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01122485
- **Lead sponsor:** Helixmith Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-12
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This product was licensed to another Korean company, no study data is available.
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01122485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01122485, "Efficacy and Safety Study of PG201 Tablet in Patients With Osteoarthritis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01122485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*